Phaedra Chrousos

Insider Reports History

Entity
Individual
Location
2200 Pennsylvania Ave Nw, Suite 300 E, Washington, DC
Signature
/s/ Phaedra Chrousos
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phaedra Chrousos:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. Director Common Stock 64.1K $268K $4.18 May 22, 2024 Direct
Vanda Pharmaceuticals Inc. Director Stock Option (right to buy) 40.2K May 22, 2024 Direct

Insider Reports Filed by Phaedra Chrousos

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VNDA Vanda Pharmaceuticals Inc. May 22, 2024 2 $0 4 May 24, 2024 Director
VNDA Vanda Pharmaceuticals Inc. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
VNDA Vanda Pharmaceuticals Inc. Jun 16, 2022 2 $0 4 Jun 21, 2022 Director
VNDA Vanda Pharmaceuticals Inc. Jun 14, 2021 1 -$40.1K 4 Jun 15, 2021 Director
VNDA Vanda Pharmaceuticals Inc. Jun 10, 2021 2 $0 4 Jun 14, 2021 Director